Sign Up to like & get
recommendations!
0
Published in 2025 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.4c01470
Abstract: Oral and intralesional tranexamic acid (TXA), used in melasma treatment, pose systemic and invasive risks, while topical TXA suffers from poor permeability (logP = -1.6) and retention. The current study aimed to develop a topically…
read more here.
Keywords:
txa pms;
product;
tranexamic acid;
txa ... See more keywords